Reported 4 months ago
This article discusses how dividend stocks are influenced by interest rates, suggesting that high-yield stocks can be appealing in a low-interest-rate environment. It highlights AbbVie and Pfizer as top choices due to their strong dividend yields, attractive valuations, and track record of value creation. AbbVie has been resilient despite market exclusivity loss for Humira, with promising sales for newer medications. Pfizer offers a robust dividend yield and promising future outlook, especially in the oncology sector. Both companies are seen as solid investments for long-term dividend investors.
Source: YAHOO